Vaccines, Synthetic

"Vaccines, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.

Descriptor ID	D014614
MeSH Number(s)	D12.776.828.868 D20.215.894.865 D23.050.865
Concept/Terms	Vaccines, Synthetic Vaccines, Synthetic Synthetic Vaccines Synthetic Immunogens Immunogens, Synthetic Semisynthetic Vaccines Semisynthetic Vaccines Vaccines, Semisynthetic Antigens, Synthetic Antigens, Synthetic Synthetic Antigens Molecular Vaccines Molecular Vaccines Vaccines, Molecular Vaccines, Chemical Chemical Vaccines Vaccines, Recombinant Vaccines, Recombinant Recombinant Vaccines

Below are MeSH descriptors whose meaning is more general than "Vaccines, Synthetic".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Recombinant Proteins [D12.776.828]
Vaccines, Synthetic [D12.776.828.868]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Vaccines, Synthetic [D20.215.894.865]
Biological Factors [D23]
Antigens [D23.050]
Vaccines, Synthetic [D23.050.865]

Below are MeSH descriptors whose meaning is more specific than "Vaccines, Synthetic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vaccines, Synthetic" by people in this website by year, and whether "Vaccines, Synthetic" was a major or minor topic of these publications.

Bar chart showing 56 publications over 22 distinct years, with a maximum of 7 publications in 2006 and 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	2	2
1996	0	1	1
2001	1	0	1
2002	0	1	1
2003	2	1	3
2004	2	0	2
2005	0	1	1
2006	1	6	7
2007	0	3	3
2008	0	2	2
2009	1	6	7
2010	1	5	6
2012	0	5	5
2013	1	1	2
2014	0	1	1
2015	0	3	3
2017	0	2	2
2018	1	1	2
2019	1	0	1
2020	0	1	1
2021	0	2	2
2022	0	1	1

Below are the most recent publications written about "Vaccines, Synthetic" by people in Profiles.

Williams CA, Wong TAS, Ball AH, Lieberman MM, Lehrer AT. Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model. Viruses. 2022 12 14; 14(12).

View in: PubMed
Lehrer AT, Chuang E, Namekar M, Williams CA, Wong TAS, Lieberman MM, Granados A, Misamore J, Yalley-Ogunro J, Andersen H, Geisbert JB, Agans KN, Cross RW, Geisbert TW. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses. Front Immunol. 2021; 12:703986.

View in: PubMed
Ricci G, Minsker K, Kapish A, Osborn J, Ha S, Davide J, Califano JP, Sehlin D, Rustandi RR, Dick LW, Vlasak J, Culp TD, Baudy A, Bell E, Mukherjee M. Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO. Sci Rep. 2021 04 01; 11(1):7432.

View in: PubMed
Haun BK, Lai CY, Williams CA, Wong TAS, Lieberman MM, Pessaint L, Andersen H, Lehrer AT. CoVaccine HT? Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. Front Immunol. 2020; 11:599587.

View in: PubMed
Lehrer AT, Wong TS, Lieberman MM, Johns L, Medina L, Feldmann F, Feldmann H, Marzi A. Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge. Vaccine. 2019 11 08; 37(47):6942-6950.

View in: PubMed
Medina LO, To A, Lieberman MM, Wong TAS, Namekar M, Nakano E, Andersen H, Yalley-Ogunro J, Greenhouse J, Higgs S, Huang YS, Vanlandingham DL, Horton JS, Clements DE, Lehrer AT. A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates. Front Immunol. 2018; 9:2464.

View in: PubMed
Hung CY, Zhang H, Castro-Lopez N, Ostroff GR, Khoshlenar P, Abraham A, Cole GT, Negron A, Forsthuber T, Peng T, Galgiani JN, Ampel NM, Yu JJ. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection. Infect Immun. 2018 11; 86(11).

View in: PubMed
Loomis KH, Lindsay KE, Zurla C, Bhosle SM, Vanover DA, Blanchard EL, Kirschman JL, Bellamkonda RV, Santangelo PJ. In Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity. Bioconjug Chem. 2018 09 19; 29(9):3072-3083.

View in: PubMed
Li X, Huang J, Kawamura A, Funakoshi R, Porcelli SA, Tsuji M. Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect. Vaccine. 2017 05 31; 35(24):3171-3177.

View in: PubMed
Lehrer AT, Wong TS, Lieberman MM, Humphreys T, Clements DE, Bakken RR, Hart MK, Pratt WD, Dye JM. Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice. Vaccine. 2018 05 24; 36(22):3090-3100.

View in: PubMed

People

Explore

Similar Concepts

Top Journals